Breaking News

Baxter to Acquire Baxa Corp

Product line adds IV nutrition and fluid delivery systems

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Baxter International, Inc. has entered into a definitive agreement to acquire Baxa Corp., a privately held company based in Englewood, CO, with additional operations in FL and the UK, for $380 million in cash. Baxa develops pharmacy technology to enhance the efficiency and safety of oral and IV dose preparation and delivery. Among Baxa’s offerings are the ExactaMix Compounder, devices that automate multi-ingredient nutritional solution compounding and the DoseEdge Pharmacy Workflow Manager, an ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters